Results of BIA survey UK R&D incentives for orphan medicines in no-deal Brexit November 2018

Chris Molloy on scale-up policy, improving treatments pipeline, LSSP, GMM regulation, LLSW, MDUK's Pedal Paddle Peak and Dr Sally Ann Forsyth OBE

The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.

The challenge of converting scientific progress into real-world access

New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.

BIA members gathered in London on Tuesday for our 26th annual Parliament Day

Drug Discovery 2026 returns to ExCeL London from 14–15 October to celebrate 20 years of collaboration and inclusion. Keynote programme includes presentation from Dr Sam Barrell CBE and panel discussion with Dr Anne Phelan, Dr Jason Mellad, Prof Sir Mene Pangalos and Prof Raghib Ali OBE